Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Ac-Ala-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 56% | Human T-cell leukemia virus type I | |
Ac-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
Ac-Gln-(R)-S-methyl-L-cysteine-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 51% | Human T-cell leukemia virus type I | |
Ac-Gln-Ile-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 85% | Human T-cell leukemia virus type I | |
Ac-Gln-Leu-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 54% | Human T-cell leukemia virus type I | |
Ac-Gln-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid- (R)-S-methyl-L-Cys-Met-NH2 | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
Ac-Gln-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Ile-Met-NH2 | HTLV-I inhibition 74% | Human T-cell leukemia virus type I | |
Ac-Gln-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Leu-Met-NH2 | HTLV-I inhibition 30% | Human T-cell leukemia virus type I | |
Ac-Gln-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Thr-Met-NH2 | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
Ac-Gln-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 66%; HTLV-I inhibition 99% | Human T-cell leukemia virus type I | |
Ac-Gln-Val-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition 49% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Ile-Met-NH2 | HTLV-I inhibition 94% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Gln-NH2 | HTLV-I inhibition 86% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Ile-NH2 | HTLV-I inhibition 78% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Leu-NH2 | HTLV-I inhibition 54% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 87% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Phe-NH2 | HTLV-I inhibition 84% | Human T-cell leukemia virus type I | |
Ac-Ile-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Val-NH2 | HTLV-I inhibition 70% | Human T-cell leukemia virus type I | |
Ac-Leu-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 83% | Human T-cell leukemia virus type I | |
Ac-Phe-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 74% | Human T-cell leukemia virus type I | |
Ac-Val-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
Ac-Val-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-NH2 | HTLV-I inhibition 77% | Human T-cell leukemia virus type I | |
H-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
H-Gln-Val-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
H-Pro-Gln-Val-allophenylnorstatine-(R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid-Val-Met-His-OH | HTLV-I inhibition 99% | Human T-cell leukemia virus type I | |
H-Pro-Gln-Val-allophenylnorstatine-Pro-NH2 | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
H-Pro-Gln-Val-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition 94% | Human T-cell leukemia virus type I | |
H-Pro-Gln-Val-allophenylnorstatine-Pro-Val-Met-NH2 | HTLV-I inhibition 86% | Human T-cell leukemia virus type I | |
H-Pro-Gln-Val-allophenylnorstatine-Pro-Val-NH2 | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I | |
H-Val-allophenylnorstatine-Pro-Val-Met-His-OH | HTLV-I inhibition below 30% | Human T-cell leukemia virus type I |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Human T-cell leukemia virus type I | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
HTLV-I protease | - |
Human T-cell leukemia virus type I |